A phase I trial of P 2202 in healthy volunteers in Canada.
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2012
At a glance
- Drugs P 2202 (Primary)
- Indications Metabolic syndrome
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 05 Oct 2012 Status changed from recruiting to completed.
- 03 Feb 2010 New trial record